NCT06534970

Brief Summary

Facial reconstruction follows removal of a malignant or benign tumor of the oral cavity or face, complex facial trauma, or resection of osteonecrosis of the jaws. It\'s a challenge that aims to restore not only the functions of the face, but also its aesthetics, which is just as crucial. A poor aesthetic result after facial reconstruction has a serious impact on patient\'s lives. To develop more personalized surgery, and to anticipate and correct poor results in the future, it is essential to better understand the factors associated with poor aesthetic results in this type of surgery, as well as their impact on the patient\'s life. This means correctly assessing the aesthetic outcome of this surgery. Today, however, aesthetic evaluation criteria remain inadequate. A number of criteria are involved in facial attractiveness, and facial symmetry is a key factor. It is generally accepted that severe facial asymmetries considerably diminish facial attractiveness. Currently, aesthetic evaluation criteria (particularly symmetry) are based primarily on the subjective perception of the surgeon or patient. However, there is a need to be able to measure facial symmetry objectively. Methods for assessing symmetry rely on the placement of anatomical landmarks and the calculation of Euclidean distance, which involves locating homologous landmarks on each side of the face and comparing the length ratios of all possible lines connecting the landmarks on each side. However, these techniques are based on measurements often on two-dimensional (2D) photographs and do not take into account the three-dimensional nature of the face. Methods for three-dimensional analysis of facial symmetry have been developed based on three-dimensional CT reconstructions. However, this technique implies the use of an irradiating imaging technique, not systematically indicated at a distance from surgery. This study aims to validate a method for analyzing facial symmetry using three-dimensional stereophotogrammetry, to identify risk factors for facial asymmetry in patients who have undergone facial reconstruction, and to assess the impact of facial asymmetry on patients\' quality of life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
13mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Jun 2025Jun 2027

First Submitted

Initial submission to the registry

July 30, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 2, 2024

Completed
10 months until next milestone

Study Start

First participant enrolled

June 3, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

November 20, 2025

Status Verified

November 1, 2025

Enrollment Period

2 years

First QC Date

July 30, 2024

Last Update Submit

November 17, 2025

Conditions

Keywords

Three-dimensional stereophotogrammetryFacial symmetry

Outcome Measures

Primary Outcomes (1)

  • Correlation coefficient between root mean square deviation (RMSE) score and surgeon's assessment score

    Day 1

Secondary Outcomes (8)

  • Intraclass Correlation Coefficient to assess intra-operator reproducibility

    Day 1

  • Intraclass Correlation Coefficient to assess inter-operator reproducibility

    Day 1

  • Demographic factors associated with objective facial asymmetry one year after facial reconstruction surgery

    Day 1

  • Clinical factors associated with objective facial asymmetry one year after facial reconstruction surgery

    Day 1

  • Therapeutic factors associated with objective facial asymmetry one year after facial reconstruction surgery

    Day 1

  • +3 more secondary outcomes

Study Arms (1)

Facial reconstruction patients

Reconstruction of the lower or middle third of the face using a pedicled flap or microanastomosed free flap following excision of a benign or malignant tumor of the oral cavity or face, osteonecrosis of the jaws, or traumatic loss of facial substance

Device: Three-dimensional stereophotogrammetryOther: Questionnaires

Interventions

Three stereoscopic photographs

Facial reconstruction patients

* SF-36 quality of life scale for general health inquiry * Rosenberg Self-Esteem Scale * Self-perception scale

Facial reconstruction patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent facial reconstruction, returning for consultation 1 year post-surgery.

You may qualify if:

  • Male or female, 18 years of age or older,
  • Patient having given non-opposition for participation in this study,
  • Reconstruction of the lower or middle third of the face by pedicled flap or microanastomosed free flap following excision of a benign or malignant tumor of the oral cavity or face, osteonecrosis of the jaws, loss of facial traumatic substance,
  • Surgery and routine follow-up performed in the 3 departments (maxillofacial surgery, ENT, plastic and reconstructive surgery) of the PROMOD cluster at Marseille's CHU Conception

You may not qualify if:

  • History of reconstruction of the lower or middle third of the face other than that being evaluated at one year for this study,
  • Subjects covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship, patients deprived of their liberty, pregnant or breast-feeding women),
  • Persons who cannot read and understand the French language well enough to be able to give their non-opposition to participating in the research.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique - Hôpitaux de Marseille

Marseille, 13005, France

RECRUITING

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • CREMIEUX François

    AP-HM

    STUDY DIRECTOR

Central Study Contacts

Nicolas GRAILLON, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 30, 2024

First Posted

August 2, 2024

Study Start

June 3, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

November 20, 2025

Record last verified: 2025-11

Locations